Stay updated on Atezolizumab Combo in Esophageal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page.

Latest updates to the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous revision label. This indicates the page content has been updated from the prior version (v3.5.3).SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page’s revision/version label has been updated from **v3.5.2** to **v3.5.3**, reflecting a website release rather than a change to the trial record itself.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded new study locations (e.g., The First Affiliated Hospital to Henan University of Science and Technology in Luoyang; Harbin Medical University Cancer Hospital; The First People’s Hospital of Foshan; The First Hospital of Jilin University in Changchun) bringing the total to 68 locations, and updated the results status with 'Results Posted' and related definitions.SummaryDifference3%

- Check69 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check76 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Atezolizumab Combo in Esophageal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Combo in Esophageal Carcinoma Clinical Trial page.